References for Cytochrome P450 Drug Interaction Table
Part 6 of 7: 2E1 Isoform

These pages contain all the literature citations referenced in the Cytochrome P450 Drug Interaction Tables (both the extensive research-oriented table and the concise clinical table). Most of these citations are hyperlinks, which bring up the abstract in the NLM's PubMed® database.

Click on the PubMed link after the drug name to perform a live MedLINE search of articles possibly related to that drug and Cytochrome P450.

Entries are organized by mode of activity (substrate, inhibitor, inducer) within specific isoform. You can quickly branch to a section by clicking on the appropriate link here:

1A2:

Substrates Inhibitors Inducers

2B6:

Substrates Inhibitors Inducers

2C19:

Substrates Inhibitors Inducers

2C9:

Substrates Inhibitors Inducers

2D6:

Substrates Inhibitors Inducers

2E1:

Substrates Inhibitors Inducers

3A4,5,7:

Substrates Inhibitors Inducers

Hint: a quick way to find a specific reference on this page is to use your web browser's Search feature: press Ctrl-F and type all or part of the name or word for which you are searching.


acetaminophen=>NAPQI: PubMed

Acetaminophen activation by human liver cytochrome P450 2E1 and 1A2.
Raucy JE, Lasker JM, Lieber CS, Black M
Arch Biochem Biophys 1989;271(2):270-283

aniline: PubMed

Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H, Nakano M, Gillam EM, Bell LC, Guengerich FP, Shimada T
Biochem Pharmacol 1996 Jul 26;52(2):301-309

benzene: PubMed

Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone.
Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, Li GL, Dosemeci M, Linet M, Zhang L, Xi L, Wacholder S, Lu W, Meyer KB, Titenko-Holland N, Stewart JT, Yin S, Ross D
Cancer Res 1997 Jul 15;57(14):2839-2842

chlorzoxazone: PubMed

Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P4502E1.
Peter R, Böcker R, Beaune PH, Iwasaki PH,Guengerich FP, Yang CS
Chem Res Toxicol 1990;3:566-573

enflurane: PubMed

ethanol: PubMed

Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1.
Garton KJ, Yuen P, Meinwald J, Thummel KE, Kharasch ED
Drug Metab Dispos 1995 Dec;23(12):1426-1430

Clinical enflurane metabolism by cytochrome P450 2E1.
Kharasch ED, Thummel KE, Mautz D, Bosse S
Clin Pharmacol Ther 1994 Apr;55(4):434-440

halothane: PubMed

Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED
J Pharmacol Exp Ther 1997 Apr;281(1):400-11

Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis.
Eliasson E, Gardner I, Hume-Smith H, de Waziers I, Beaune P, Kenna JG
Chem Biol Interact 1998 Nov 6;116(1-2):123-41

isoflurane: PubMed

methoxyflurane: PubMed

N,N-dimethylformamide: PubMed

Investigation of the mechanistic basis of N,N-dimethylformamide toxicity. Metabolism of N,N-dimethylformamide and its deuterated isotopomers by cytochrome P450 2E1.
Mraz J, Jheeta P, Gescher A, Hyland R, Thummel K, Threadgill MD
Chem Res Toxicol 1993 Mar;6(2):197-207

sevoflurane: PubMed

theophylline: PubMed

Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics.
Loi CM, Day JD, Jue SG, Bush ED, Costello P, Dewey LV, Vestal RE
Clin Pharmacol Ther 1989:45(5):476-486


diethyl-dithiocarbamate: PubMed

Role of human cytochrome P450 2E1 in the oxidation of many low molecular weight cancer suspects.
Guengerich FP, Kim DH, Iwasaki M
Chem Res Toxicol 1991; 4:168-179

disulfiram: PubMed

Single dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1.
Kharasch ED, Thummel KE, Mhyre J, Lillibridge JH
Clin Pharmacol Ther 1993;53:643-650


ethanol: PubMed

isoniazid: PubMed

Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans.
Zand R, Nelson SD, Slattery JT, Thummel KE, Kalhorn TF, Adams SP, Wright JM
Clin Pharmacol Ther 1993;54(2):142-149